{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:12:42Z","timestamp":1793931162229,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-018-0955-6","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T21:57:09Z","timestamp":1546984629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db\/db mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Li","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","volume":"44","author":"JW Chisholm","year":"2003","unstructured":"Chisholm JW, Hong J, Mills SA, Lawn RM. The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse. J Lipid Res. 2003;44:2039\u201348.","journal-title":"J Lipid Res"},{"key":"955_CR2","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","volume":"13","author":"K Qureshi","year":"2007","unstructured":"Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13:3540\u201353.","journal-title":"World J Gastroenterol"},{"key":"955_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.24491","volume":"54","author":"N Bhala","year":"2011","unstructured":"Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54:1208\u201316.","journal-title":"Hepatology"},{"key":"955_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u201323.","journal-title":"Hepatology"},{"key":"955_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1262-3636(08)74599-3","volume":"34","author":"C Postic","year":"2008","unstructured":"Postic C, Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 2008;34:643\u20138.","journal-title":"Diabetes Metab"},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2337\/db15-1024","volume":"65","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Liu H, Yu J, Zhao Z, Xiao F, Xia T, Wang C, Li K, Deng J, Guo Y, et al. Activation of ERK1\/2 ameliorates liver steatosis in leptin receptor-deficient (db\/db) mice via stimulating ATG7-dependent autophagy. Diabetes. 2016;65:393\u2013405.","journal-title":"Diabetes"},{"key":"955_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2015;62:720\u201333.","journal-title":"J Hepatol"},{"key":"955_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","volume":"49","author":"NU Ashraf","year":"2015","unstructured":"Ashraf NU, Sheikh TA. Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease. Free Radic Res. 2015;49:1405\u201318.","journal-title":"Free Radic Res"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.msec.2016.10.045","volume":"71","author":"E Esposito","year":"2017","unstructured":"Esposito E, Drechsler M, Mariani P, Panico AM, Cardile V, Crasci L, Carducci F, Graziano ACE, Cortesi R, Puglia C. Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.). Mater Sci Eng C Mater Biol Appl. 2017;71:669\u201377.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"955_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cbi.2018.02.001","volume":"284","author":"HO Abou-Hany","year":"2018","unstructured":"Abou-Hany HO, Atef H, Said E, Elkashef HA, Salem HA. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats. Chem Biol Interact. 2018;284:90\u2013100.","journal-title":"Chem Biol Interact"},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1159\/000479212","volume":"42","author":"S Li","year":"2017","unstructured":"Li S, Liu X, Lei J, Yang J, Tian P, Gao Y. Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-kappaB. Cell Physiol Biochem. 2017;42:1481\u201392.","journal-title":"Cell Physiol Biochem"},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12031-017-0899-8","volume":"61","author":"X Yang","year":"2017","unstructured":"Yang X, Huo F, Liu B, Liu J, Chen T, Li J, Zhu Z, Lv B. Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of PI3K\/Akt signaling pathway. J Mol Neurosci. 2017;61:581\u20139.","journal-title":"J Mol Neurosci"},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopha.2017.12.077","volume":"98","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Mohammadi MT, Sahebkar A. Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats. Biomed Pharmacother. 2018;98:333\u20137.","journal-title":"Biomed Pharmacother"},{"key":"955_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.intimp.2017.07.012","volume":"50","author":"H Yosri","year":"2017","unstructured":"Yosri H, Elkashef WF, Said E, Gameil NM. Crocin modulates IL-4\/IL-13 signaling and ameliorates experimentally induced allergic airway asthma in a murine model. Int Immunopharmacol. 2017;50:305\u201312.","journal-title":"Int Immunopharmacol"},{"key":"955_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/antiox2040293","volume":"2","author":"M Mashmoul","year":"2013","unstructured":"Mashmoul M, Azlan A, Khaza'ai H, Yusof BN, Noor SM. Saffron: a natural potent antioxidant as a promising anti-obesity drug. Antioxid. 2013;2:293\u2013308.","journal-title":"Antioxid"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0960327114538989","volume":"34","author":"E Altinoz","year":"2015","unstructured":"Altinoz E, Oner Z, Elbe H, Cigremis Y, Turkoz Y. Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats. Hum Exp Toxicol. 2015;34:127\u201334.","journal-title":"Hum Exp Toxicol"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3906\/sag-1506-108","volume":"46","author":"O Hazman","year":"2016","unstructured":"Hazman O, Aksoy L, Buyukben A. Effects of crocin on experimental obesity and type-2 diabetes. Turk J Med Sci. 2016;46:1593\u2013602.","journal-title":"Turk J Med Sci"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajo.2018.03.007","volume":"190","author":"S Sepahi","year":"2018","unstructured":"Sepahi S, Mohajeri SA, Hosseini SM, Khodaverdi E, Shoeibi N, Namdari M, Tabassi SAS. Effects of Crocin on diabetic maculopathy: a placebo-controlled randomized clinical trial. Am J Ophthalmol. 2018;190:89\u201398.","journal-title":"Am J Ophthalmol"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ecoenv.2012.06.003","volume":"83","author":"HA El-Beshbishy","year":"2012","unstructured":"El-Beshbishy HA, Hassan MH, Aly HA, Doghish AS, Alghaithy AA. Crocin \"saffron\" protects against beryllium chloride toxicity in rats through diminution of oxidative stress and enhancing gene expression of antioxidant enzymes. Ecotoxicol Environ Saf. 2012;83:47\u201354.","journal-title":"Ecotoxicol Environ Saf"},{"key":"955_CR20","doi-asserted-by":"crossref","unstructured":"Cusi K: Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012, 142:711\u2013725.e716.","DOI":"10.1053\/j.gastro.2012.02.003"},{"key":"955_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/liv.13185","volume":"36","author":"L Valenti","year":"2016","unstructured":"Valenti L, Bugianesi E, Pajvani U, Targher G. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int. 2016;36:1563\u201379.","journal-title":"Liver Int"},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343\u201351.","journal-title":"J Clin Invest"},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1073\/pnas.95.11.5987","volume":"95","author":"JD Horton","year":"1998","unstructured":"Horton JD, Bashmakov Y, Shimomura I, Shimano H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A. 1998;95:5987\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"955_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1172\/JCI27300","volume":"116","author":"DB Savage","year":"2006","unstructured":"Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, Wang A, Zhang XM, Cline GW, Yu XX, Geisler JG, et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest. 2006;116:817\u201324.","journal-title":"J Clin Invest"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1172\/JCI200523962","volume":"115","author":"G Jiang","year":"2005","unstructured":"Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, et al. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest. 2005;115:1030\u20138.","journal-title":"J Clin Invest"},{"key":"955_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, Viscarra J, Kim SJ, Sul HS. Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015;16:678\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"955_CR27","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1096\/fj.10-173716","volume":"25","author":"E Moran-Salvador","year":"2011","unstructured":"Moran-Salvador E, Lopez-Parra M, Garcia-Alonso V, Titos E, Martinez-Clemente M, Gonzalez-Periz A, Lopez-Vicario C, Barak Y, Arroyo V, Claria J. Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 2011;25:2538\u201350.","journal-title":"FASEB J"},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","volume":"1821","author":"AP Jensen-Urstad","year":"2012","unstructured":"Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta. 2012;1821:747\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"955_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology. 2016;157:570\u201385.","journal-title":"Endocrinology"},{"key":"955_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2018.08.001","volume":"655","author":"B Bhatt-Wessel","year":"2018","unstructured":"Bhatt-Wessel B, Jordan TW, Miller JH, Peng L. Role of DGAT enzymes in triacylglycerol metabolism. Arch Biochem Biophys. 2018;655:1\u201311.","journal-title":"Arch Biochem Biophys"},{"key":"955_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner A, Polizzi A, Fouche E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Regnier M, Lukowicz C, Benhamed F, et al. Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut. 2016;65:1202\u201314.","journal-title":"Gut"},{"key":"955_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tem.2017.10.011","volume":"29","author":"AM Lundsgaard","year":"2018","unstructured":"Lundsgaard AM, Fritzen AM, Kiens B. Molecular regulation of fatty acid oxidation in skeletal muscle during aerobic exercise. Trends Endocrinol Metab. 2018;29:18\u201330.","journal-title":"Trends Endocrinol Metab"},{"key":"955_CR33","doi-asserted-by":"crossref","unstructured":"Raas Q, Saih FE, Gondcaille C, Trompier D, Hamon Y, Leoni V, Caccia C, Nasser B, Jadot M, Menetrier F, et al. A microglial cell model for acyl-CoA oxidase 1 deficiency. Biochim Biophys Acta Mol Cell Biol Lipids. 2018.","DOI":"10.1016\/j.bbalip.2018.10.005"},{"key":"955_CR34","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.M111.235044","volume":"286","author":"A Vila-Brau","year":"2011","unstructured":"Vila-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF. Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. J Biol Chem. 2011;286:20423\u201330.","journal-title":"J Biol Chem"},{"key":"955_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4196\/kjpp.2009.13.6.449","volume":"13","author":"E Seo","year":"2009","unstructured":"Seo E, Park EJ, Joe Y, Kang S, Kim MS, Hong SH, Park MK, Kim DK, Koh H, Lee HJ. Overexpression of AMPKalpha1 ameliorates fatty liver in Hyperlipidemic diabetic rats. Korean J Physiol Pharmacol. 2009;13:449\u201354.","journal-title":"Korean J Physiol Pharmacol"},{"key":"955_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2016.04.111","volume":"474","author":"HA Zhang","year":"2016","unstructured":"Zhang HA, Yang XY, Xiao YF. AMPKalpha1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochem Biophys Res Commun. 2016;474:364\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"955_CR37","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1002\/jcp.25715","volume":"232","author":"CO Souza de","year":"2017","unstructured":"de Souza CO, Teixeira AAS, Biondo LA, Lima Junior EA, Batatinha HAP, Rosa Neto JC. Palmitoleic acid improves metabolic functions in fatty liver by PPARalpha-dependent AMPK activation. J Cell Physiol. 2017;232:2168\u201377.","journal-title":"J Cell Physiol"},{"key":"955_CR38","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.2337\/db05-1322","volume":"55","author":"MJ Yoon","year":"2006","unstructured":"Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 2006;55:2562\u201370.","journal-title":"Diabetes"},{"key":"955_CR39","doi-asserted-by":"crossref","unstructured":"Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutrients. 2017;9.","DOI":"10.3390\/nu9040387"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0955-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:14:08Z","timestamp":1578442448000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0955-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0955-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and in accordance with ARRIVE and NIH guidelines for animal welfare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"11"}}